SOON Sonova Holding AG

SWX · CH · Healthcare · Medical Devices · sonova.com

251.60CHF+1.29%Mkt Cap: 17.06B $P/E: 27.92Today

Sonova Holding AG manufactures and sells hearing care solutions for children and adults in Switzerland, the United States, rest of the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates through …

Industry Peers

Medical Devices

Screen all

ABT

Abbott Laboratories Common Stock

$169.83BUSDP/E 31.6

MDT

Medtronic plc. Ordinary Shares

$110.49BUSDP/E 21.2

SYK

Stryker Corporation Common Stock

$105.65BUSDP/E 28.5

BSX

Boston Scientific Corporation Common Stock

$61.74BUSDP/E 17.2

Edwards Lifesciences Corporation Common Stock

$49.03BUSDP/E 50.7

SHL

Siemens Healthineers AG

$46.06BUSDP/E 19.2

DXCM

DexCom, Inc. - Common Stock

$32.21BUSDP/E 33.7

GEHC

GE HealthCare Technologies Inc. - Common Stock

$29.24BUSDP/E 14.8

PHG

Koninklijke Philips N.V. NY Registry Shares

$23.38BUSDP/E 18.5

PHIA

Koninklijke Philips N.V.

$22.58BUSDP/E 18.5

STE

STERIS plc (Ireland) Ordinary Shares

$20.33BUSDP/E 25.5

ZBH

Zimmer Biomet Holdings, Inc. Common Stock

$16.84BUSDP/E 21.4

PEN

Penumbra, Inc. Common Stock

$12.51BUSDP/E 77.8

TXG

10x Genomics, Inc. - Common Stock

$12.18BUSD

SNN

Smith & Nephew SNATS, Inc. Common Stock

$11.06BUSDP/E 18.0

GMED

Globus Medical, Inc. Class A Common Stock

Bio-Rad Laboratories, Inc. Class A Common Stock

$9.88BUSDP/E 45.0

GKOS

Glaukos Corporation Common Stock

$9.66BUSD

BRKR

Bruker Corporation - Common Stock

$9.64BUSD

Key Statistics

Company

Market Cap17.06B USD

Enterprise Value18.00B USD

Revenue (TTM)4.12B USD

Gross Profit3.03B USD

Net Income (TTM)491.45M USD

Revenue/Share60.53 CHF

Last Price251.60 CHF

Fiscal Year EndMar 2026

MR QuarterMar 2026

Employees18.6K

CountryCH

SectorHealthcare

IndustryMedical Devices

ISINUS83569C1027

Valuation

P/E (Trailing)27.92

P/E (Forward)20.66

PEG1.42

EV/EBITDA18.74

EV/Revenue4.37

P/S4.09

P/B5.65

EPS (TTM)9.01

EPS (Forward)12.02

52W Range

163.0095% of range255.80

52W High255.80 CHF

52W Low163.00 CHF

Profitability

Gross Margin73.72%

Oper. Margin19.55%

EBITDA Margin23.34%

Profit Margin11.94%

ROE16.47%

ROA7.65%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF838.29M USD

CapEx (TTM)117.21M USD

FCF Margin9.60%

FCF Yield2.32%

Net Debt1.13B USD

Net Debt/EBITDA1.18

Balance Sheet

Debt/Equity0.65

Current Ratio1.75

Quick Ratio1.16

Book Value/Sh44.00 CHF

Cash/Share12.15 CHF

Dividends

Fwd Div Rate4.70 CHF

Trail. Div Rate4.70 CHF

Div. Yield1.89%

5Y Avg Yield1.57%

Payout Ratio48.83%

Ex-Div DateJun 19, 2026

Pay DateJun 17, 2024

Splits

Last Split151:150

Split DateJun 16, 2020

Analyst Consensus

Rating2.7 (Hold)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)235.68 CHF

Upside (mean)-6.3%

Target Range170.00 CHF – 350.00 CHF

170.00-6.3% to mean350.00

# Analysts19

Ownership

Shares Out.59.40M

Float59.22M

Insiders17.50%

Institutions48.98%

Technical

SMA 50236.01 (+6.6%)

SMA 200206.80 (+21.7%)

Beta1.11

S&P 52W Chg14.58%

Avg Vol (30d)143.34K

Avg Vol (10d)115.53K

Technical Indicators

RSI (14)68.6

MACD8.3437

MACD Signal8.5709

MACD Hist.-0.2272

BB Upper254.09 CHF

BB Middle241.69 CHF

BB Lower229.29 CHF

BB Width10.26%

ATR (14)4.575 CHF

Vol Ratio (20d)0.53x